Comment: The most recent Banff classification of renal allograft pathology.
Comment: A recent review of risk factors associated with post-transplant diabetes mellitus.
Comment: Reviews strategies for managing cytomegalovirus in transplant recipients.
Comment: A comprehensive review on BK virus nephropathy.
Comment: Discusses corticosteroid withdrawal from maintenance immunosuppressive therapy; argues that it is still early to adopt this strategy.
Comment: A review of simultaneous pancreas-kidney transplantation in diabetes mellitus type 1.
Comment: Shows that the use of a regimen that includes mycophenolate, corticosteroids and low dose tacrolimus is advantageous for renal function, allograft survival and acute rejection rates.
Comment: Discusses risk factors that confer greater risk of CVD morbidity and mortality in the post transplant period.
Comment: Shows better graft function and fewer endocrine side-effects in mycophenolate/tacrolimus regimen when compared to sirolimus/tacrolimus regimen.
Comment: Demonstrates a biphasic increase in skin cancer incidence following kidney transplantation; this was determined by the age at transplantation.
Comment: Highlights the role of the interaction between the immune system and common viral infections in the etiology of cancer.
Comment: Shows that tacrolimus and sirolimus have a synergistic effect on islet cell apoptosis in Sprague dawley rats.
Comment: A meta-analysis showing a higher risk for developing post-transplant diabetes mellitus with tacrolimus compared to cyclosporine.
Comment: Shows that sirolimus is associated with worsening insulin resistance.
Comment: Suggests that certain genetic polymorphisms may predict patients' risk for developing post-transplant diabetes mellitus.
Comment: Demonstrates a significant relationship between post-transplant hyperglycemia and cardiovascular events.
Comment: A review that discusses the pathogenesis, complications and management of post-transplant diabetes mellitus.
Comment: Shows that the rates for most malignancies are higher after transplantation; concludes that cancer prevention should be a main focus in kidney transplant recipients.
Comment: Analyzes data from the United Renal Data System and identifies risk factors associated with post-transplant diabetes mellitus.
Comment: Shows that immunosuppressive regimens including high dose calcineurin inhibitors increase risk for post-transplant diabetes mellitus.
Comment: Shows that peripheral vascular disease after transplantation is associated with reduced survival; it appears that transplantation does not accelerate or retard its progression.
Comment: A comprehensive review on infections in organ-transplant recipients
Comment: Identifies risk factors for developing non-melanoma skin cancer post-transplantation.
Comment: Discusses the approach for evaluation of potential transplant recipients.
Comment: Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients
Comment: The national data registry that collects and analyzes information on the end-stage renal disease population in the U.S.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Complete Product Information.